Taysha Gene Therapies, Inc. - TSHA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 6.3% | 18,000,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ryan Wilder | 6.3% | 18,000,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 7.0% | 20,689,084 | View |
| May 15, 2026 | SCHEDULE 13G/A | Roderick Wong | 7.0% | 20,689,084 | View |
| Feb 17, 2026 | SCHEDULE 13G | Vestal Point Capital, LP | 5.0% | 13,750,000 | View |
| Feb 17, 2026 | SCHEDULE 13G | Ryan Wilder | 5.0% | 13,750,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 8.3% | 23,407,133 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Roderick Wong | 8.3% | 23,407,133 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 4.9% | 13,528,366 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 4.9% | 13,528,366 | View |
| Jan 21, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 6.5% | 17,852,291 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.